text-only page produced automatically by LIFT Text Transcoder Skip all navigation and go to page contentSkip top navigation and go to directorate navigationSkip top navigation and go to page navigation
National Science Foundation
Search  
Awards
design element
Search Awards
Recent Awards
Presidential and Honorary Awards
About Awards
Grant Policy Manual
Grant General Conditions
Cooperative Agreement Conditions
Special Conditions
Federal Demonstration Partnership
Policy Office Website


Award Abstract #0733868
SGER: Biophotonics for Diagnosis of Pancreatic Cancer


NSF Org: CBET
Division of Chemical, Bioengineering, Environmental, and Transport Systems
divider line
divider line
Initial Amendment Date: May 1, 2007
divider line
Latest Amendment Date: June 6, 2008
divider line
Award Number: 0733868
divider line
Award Instrument: Standard Grant
divider line
Program Manager: Leon Esterowitz
CBET Division of Chemical, Bioengineering, Environmental, and Transport Systems
ENG Directorate for Engineering
divider line
Start Date: July 1, 2007
divider line
Expires: December 31, 2008 (Estimated)
divider line
Awarded Amount to Date: $160349
divider line
Investigator(s): Vadim Backman v-backman@northwestern.edu (Principal Investigator)
Randall Brand (Co-Principal Investigator)
Hemant Roy (Co-Principal Investigator)
divider line
Sponsor: Northwestern University
633 CLARK ST
EVANSTON, IL 60208 847/491-3003
divider line
NSF Program(s): BIOPHOTONICS, IMAGING &SENSING
divider line
Field Application(s): 0000099 Other Applications NEC
divider line
Program Reference Code(s): OTHR, 9237, 7237, 005E, 0000
divider line
Program Element Code(s): 7236

ABSTRACT

CBET-0733868 Backman Pancreatic cancer (PC) has the worst prognosis of any major cancer, with a five-year survival rate below 5%. The reasons for the lethality of PC relates to its tendency to be

diagnosed at a late stage given that potentially curable stages of disease are often

clinically silent. Survival rate dramatically depends on the stage at which PC is

diagnosed. However, pancreatic cancer is insidious in that the development of symptoms

generally portend unresectable and hence uncurable disease. One of the major hurdles

preventing screening for PC is that essentially any interrogation of the pancreas may lead

to serious complications (~20% complication rate). Thus, finding a pre-screening method in

which patients are risk-stratified would be critical for designing screening strategies.

This project focuses on development of a biophotonics approach (a partial wave spectroscopic microscopic technique), to address this problem.


PUBLICATIONS PRODUCED AS A RESULT OF THIS RESEARCH

(Showing: 1 - 1 of 1).

Y. Liu, R. E. Brand, V. Turzhitsky, Y. L. Kim, H. K. Roy, N. Hasabou, C. Sturgis, D. Shah, C. Hall, V. Backman.  "Optical Markers in Duodenal Mucosa Predict the Presence of Pancreatic Cancer,"  Clinical Cancer Research,  v.13,  2007,  p. 4392.


(Showing: 1 - 1 of 1).

 

Please report errors in award information by writing to: awardsearch@nsf.gov.

 

 

Print this page
Back to Top of page
  Web Policies and Important Links | Privacy | FOIA | Help | Contact NSF | Contact Web Master | SiteMap  
National Science Foundation
The National Science Foundation, 4201 Wilson Boulevard, Arlington, Virginia 22230, USA
Tel: (703) 292-5111, FIRS: (800) 877-8339 | TDD: (800) 281-8749
Last Updated:
April 2, 2007
Text Only


Last Updated:April 2, 2007